News

Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.